Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Li Ning (2331 HK)
Watchlist
337
Analysis
Consumer Discretionary
•
China
Li Ning Company Limited researches, designs, manufactures, distributes, and retails sports footwear, apparel and accessories for sport and leisure use.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Giant Biogene
•
03 Nov 2022 09:50
Giant Biogene IPO Trading - Demand Was Relatively Better but Still Weak
Giant Biogene (GB) raised around US$70m by pricing its HK IPO at the low-end. In this note we talk about the trading dynamics.
Sumeet Singh
Follow
225 Views
Share
bullish
•
Quantitative Analysis
•
01 Nov 2022 12:06
Hong Kong Connect Flows Monthly: $8.1bn Inflows in October
We analyzed the Hong Kong Connect Scheme for October and highlight flows for Tencent, Meituan, Wuxi Biologics, Li Auto, Kuaishou, Tsingtao Brewery.
Ke Yan, CFA, FRM
Follow
161 Views
Share
bullish
•
Quantitative Analysis
•
30 Oct 2022 10:06
HK Short Interest Weekly: BYD, Conch Venture, Shandong Weigao.
We analyzed the latest HK SFC report for aggregate short position as of {} and highlight short interest changes in BYD, Conch Venture, Shandong...
Ke Yan, CFA, FRM
Follow
203 Views
Share
bullish
•
Giant Biogene
•
25 Oct 2022 11:17
Giant Biogene IPO - Reasonable Valuation but in Unreasonable Markets
Giant Biogene is now looking to raise around US$80m in its Hong Kong IPO, down from its earlier target of US$500m raising.
Sumeet Singh
Follow
225 Views
Share
bullish
•
Quantitative Analysis
•
23 Oct 2022 09:37
Hong Kong Connect Flows (Oct 21st): $3.2bn Inflows
We analyzed the Hong Kong Connect Scheme for last week and highlight $3.2bn inflows last week and flows for Tencent, Meituan, Wuxi Biologics.
Ke Yan, CFA, FRM
Follow
246 Views
Share
First
Previous
28
29
30
31
32
33
34
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x